187 related articles for article (PubMed ID: 31802190)
1. Is ascites CEA a risk factor for peritoneal carcinomatosis in colorectal cancer?: a long-term follow-up study.
Kim BC; Bae JH; Park SM; Won DY; Lee IK
Int J Colorectal Dis; 2020 Jan; 35(1):147-155. PubMed ID: 31802190
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of Carcinoembryonic Antigen in Ascites for Colorectal Cancer with Peritoneal Carcinomatosis.
Song SE; Choi P; Kim JH; Jung K; Kim SE; Moon W; Park MI; Park SJ
Korean J Gastroenterol; 2018 Jun; 71(6):332-337. PubMed ID: 29943560
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of CEA and CA 19-9 tumor markers combined with cytology from peritoneal fluid in colorectal cancer.
Lee IK; Kim DH; Gorden DL; Lee YS; Sung NY; Park GS; Kim HJ; Kang WK; Park JK; Ahn CH; Kim JG; Jeon HM; Oh ST
Ann Surg Oncol; 2009 Apr; 16(4):861-70. PubMed ID: 19189191
[TBL] [Abstract][Full Text] [Related]
4. Use of ascitic CEA levels as a predictive value for distant metastasis in high-risk stage II and III colorectal cancer.
Al-Sawat A; Bea JH; Han SR; Lee HJ; Yoon MR; Lee YS; Lee DS; Lee CS; Lee IK
Int J Colorectal Dis; 2022 Feb; 37(2):365-372. PubMed ID: 34850277
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ascitic fluid cell block for diagnosing primary ovarian, peritoneal, and tubal cancer in patients with peritoneal carcinomatosis with ascites.
Uehara T; Yoshida H; Fukuhara M; Yoshida M; Motoi N; Sugawara S; Sone M; Arai Y; Tamura K; Uno M; Ishikawa M; Kato T
Gynecol Oncol; 2020 May; 157(2):398-404. PubMed ID: 32063274
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites.
Jung M; Jeung HC; Lee SS; Park JY; Hong S; Lee SH; Noh SH; Chung HC; Rha SY
J Cancer Res Clin Oncol; 2010 Apr; 136(4):517-26. PubMed ID: 19774395
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of doubling time in patients undergoing radical surgery for metachronous peritoneal metastases of colorectal cancer.
Miyake H; Murono K; Nagata H; Nozawa H; Kawai K; Hata K; Tanaka T; Nishikawa T; Shuno Y; Sasaki K; Ishihara S
Int J Colorectal Dis; 2019 May; 34(5):801-809. PubMed ID: 30739186
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of intraperitoneal minimal free cancer cells between colorectal and gastric cancer patients using quantitative RT-PCR: possible reason for rare peritoneal recurrence in colorectal cancer.
Hara M; Nakanishi H; Jun Q; Kanemitsu Y; Ito S; Mochizuki Y; Yamamura Y; Kodera Y; Tatematsu M; Hirai T; Kato T
Clin Exp Metastasis; 2007; 24(3):179-89. PubMed ID: 17487561
[TBL] [Abstract][Full Text] [Related]
9. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
10. Accessing new prognostic significance of preoperative carcinoembryonic antigen in colorectal cancer receiving tumor resection: More than positive and negative.
Cai Z; Xiao J; He X; Ke J; Zou Y; Chen Y; Wu X; Li X; Wang L; Wang J; Lan P; Wu X
Cancer Biomark; 2017; 19(2):161-168. PubMed ID: 28128739
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal carcinomatosis in colorectal cancer: Defining predictive factors for successful cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - A pilot study.
Mahmoud AM; Ismail YM; Hussien A; Debaky Y; Ahmed IS; Mikhael HSW; Moneer M
J Egypt Natl Canc Inst; 2018 Dec; 30(4):143-150. PubMed ID: 30472198
[TBL] [Abstract][Full Text] [Related]
13. ASCITIC AND SERUM LEVELS OF TUMOR BIOMARKERS (CA 72-4, CA 19-9, CEA AND CA 125) IN DISCRIMINATION OF CAUSE OF ASCITES: A PROSPECTIVE STUDY.
Jain T; Ram S; Kumar H; Saroch A; Sharma V; Singh H
Arq Gastroenterol; 2022; 59(2):198-203. PubMed ID: 35830029
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal carcinomatosis in t4 colorectal cancer: occurrence and risk factors.
van Santvoort HC; Braam HJ; Spekreijse KR; Koning NR; de Bruin PC; de Vries Reilingh TS; Boerma D; Smits AB; Wiezer MJ; van Ramshorst B
Ann Surg Oncol; 2014 May; 21(5):1686-91. PubMed ID: 24398543
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of peritoneal CEA levels following colorectal cancer surgery.
Berkovich L; Shpitz B; Ghinea R; Greemland I; Kravtsov V; Kidron D; Mishaeli M; Avital S
J Surg Oncol; 2014 Sep; 110(4):458-62. PubMed ID: 24910092
[TBL] [Abstract][Full Text] [Related]
16. Value of carcinoembryonic antigen (CEA) and cholesterol assays of ascitic fluid in cases of inconclusive cytology.
Gulyás M; Kaposi AD; Elek G; Szollár LG; Hjerpe A
J Clin Pathol; 2001 Nov; 54(11):831-5. PubMed ID: 11684715
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of cancer stem-like cells and cancer-associated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgery.
Nakamura K; Iinuma H; Aoyagi Y; Shibuya H; Watanabe T
Oncology; 2010; 78(5-6):309-15. PubMed ID: 20616575
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal-Free Cancer Cells Represent a Major Prognostic Factor in Colorectal Peritoneal Carcinomatosis.
Trilling B; Cotte E; Vaudoyer D; Isaac S; Piaton E; Maurice C; Glehen O; Passot G
Dis Colon Rectum; 2016 Jul; 59(7):615-22. PubMed ID: 27270513
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection.
Katsuragi K; Yashiro M; Sawada T; Osaka H; Ohira M; Hirakawa K
Br J Cancer; 2007 Aug; 97(4):550-6. PubMed ID: 17667927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
